Anteris Technologies Secures US FDA Early Feasibility Study Approval for Heart Valve Device System – Marketscreener.com
Related Articles
Anteris Technologies completes treatment of second cohort in first-in-human study for transcatheter heart valve system – Proactive Investors Australia
11:42 Tue 31 May 2022Anteris Technologies cements position as serious player in TAVR market with in-vivo demonstration of ComASUR™ Transfemoral Delivery System “We are thrilled…
Data Centre In Space Feasibility Study To Be Led By Thales – Silicon UK
All Tech News > category news Cloud > category news Datacentre Data Centre In Space Feasibility Study To Be Led By Thales Talk about cloud…
FDA Proposes Rule On Use Of Innovative Technologies And Other Conditions Of Use To Expand Options For Nonprescription Drug Products – Healthcare – United States – Mondaq
Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy. On…
Improving Medicare Coverage Of Innovative Technologies – healthaffairs.org
Can’t sign in? Forgot your password?Enter your email address below and we will send you the reset instructionsIf the address matches an existing account you…
Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System – Yahoo Finance
SUZHOU, China, Nov. 25, 2022 /PRNewswire/ — inQB8 Medical Technologies, LLC (inQB8), in Partnership with Peijia Medical Limited (Peijia, (9996.HK)), announced today that it has successfully…